Fact sheet: Parvest EqWdHthCre

Fund information

Fund name
Parvest Equity World Health Care Classic Cap EUR
Fund company manager
BNP Paribas Asset Management L
Fund type
SIB
Fund manager(s)
Jon Stephenson
since 02/05/2016
Fund objective
Increase the value of its assets over the medium term.
Benchmark
MSCI World [S] Health Care 10/40 (NR)
Investment style
None
Investment method
Shares

Performance snapshot

Sector
Fund
Sector
Fund
Sector
Fund

Quick stats

1 Year return

6.17 %

1 Year rank in sector

24/30

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 311.3 m

FE Risk score

151

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    76.58%
  • Switzerland
    8.2%
  • UK
    7.52%
  • Germany
    5.89%
  • Japan
    1.27%
  • Pharmaceuticals
    42.9%
  • Biotechnology/Medical
    26.64%
  • Healthcare & Medical Products
    15.96%
  • Health Care
    14.5%
  • US Equities
    76.58%
  • Swiss Equities
    8.2%
  • UK Equities
    7.52%
  • German Equities
    5.89%
  • Japanese Equities
    1.27%

Performance vs. Sector

Sector
Fund
Sector
Fund
Sector
Fund

Cumulative performance

1m6m1y3y5y
Fund-0.19 %-4.57 %6.17 %27.07 %85.4 %
Sector0.81 %7.11 %14.15 %29.43 %97.51 %
Rank within sector27 / 3131 / 3124 / 3016 / 2817 / 24
Quartile th4 th4 th4 th3 rd3 rd

Calendar performance

YTD-20172016201520142013
Fund3.06 %-8.75 %15.07 %34.91 %31.67 %
Sector17.12 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector29 / 3013 / 306 / 2811 / 2519 / 24
Quartile th4 th2 nd1 st2 nd4 th

Risk statistics

Alpha-0.69
Beta1.02
Sharpe0.14
Volatility17.34
Tracking error7.4
Information ratio-0.11
R-Squared0.81

Price movement

52 week high995.53
52 week low804.23
Current bid price0
Current offer price0
Current mid price919.74

Holdings by region

  • 76.58% USA
  • 8.2% Switzerland
  • 7.52% UK
  • 5.89% Germany
  • 1.27% Japan
  • 0.54% Ireland

Holdings by sector

  • 42.9% Pharmaceuticals
  • 26.64% Biotechnology/Medical
  • 15.96% Healthcare & Medical Products
  • 14.5% Health Care

Holdings by asset type

  • 76.58% US Equities
  • 8.2% Swiss Equities
  • 7.52% UK Equities
  • 5.89% German Equities
  • 1.27% Japanese Equities
  • 0.54% Irish Equities

Individual holdings

  • 7.25% UNITEDHEALTH GROUP INC
  • 6.52% CELGENE CORP
  • 5.92% ALLERGAN INC
  • 5.09% MERCK & CO INC(NEW)
  • 5.03% BRISTOL MYERS SQUIBB SA
  • 4.88% BOSTON SCIENTIFIC CORP
  • 4.46% EDWARDS LIFESCIENCES CORP
  • 4.1% JAZZ PHARMACEUTICALS PLC
  • 3.98% NOVARTIS AG
  • 3.67% CENTENE CORP(DEL)